JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.12, ss.309-313, 2016 (SCI İndekslerine Giren Dergi)
Background: Uterine sarcomas are rare, malignant, gynecological tumors and show diverse histopathological features. Therefore, there is no consensus on risk factors for poor outcome and optimal treatment. The aim of this retrospective analysis is to report the clinical outcome of patients with uterine sarcoma treated at a single center.